Cargando…
Altered Fc galactosylation in IgG(4) is a potential serum marker for chronic lung disease
Characterising chronic lung diseases is challenging. New, less invasive diagnostics are needed to decipher disease pathologies and subphenotypes. Fc galactosylation is known to affect IgG function, and is altered in autoimmune disorders and under other pathological conditions. We tested how well Fc...
Autores principales: | Heyder, Tina, Wiklundh, Emil, Eklund, Anders, James, Anna, Grunewald, Johan, Zubarev, Roman A., Lundström, Susanna L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066530/ https://www.ncbi.nlm.nih.gov/pubmed/30083550 http://dx.doi.org/10.1183/23120541.00033-2018 |
Ejemplares similares
-
SpotLight Proteomics—A IgG-Enrichment Phenotype Profiling Approach with Clinical Implications
por: Lundström, Susanna L., et al.
Publicado: (2019) -
IgG Fc galactosylation predicts response to methotrexate in early rheumatoid arthritis
por: Lundström, Susanna L., et al.
Publicado: (2017) -
IgG1 Fc N-glycan galactosylation as a biomarker for immune activation
por: de Jong, Sanne E., et al.
Publicado: (2016) -
IgG Antibodies to Cyclic Citrullinated Peptides Exhibit Profiles Specific in Terms of IgG Subclasses, Fc-Glycans and a Fab-Peptide Sequence
por: Lundström, Susanna L., et al.
Publicado: (2014) -
Fc galactosylation of anti-platelet human IgG1 alloantibodies enhances complement activation on platelets
por: van Osch, Thijs L.J., et al.
Publicado: (2022)